Is there a harder problem in science than diagnosing and treating forms of dementia? If it was a simple solution, it would have been cracked by now, said Alison Howie, chief commercial officer of neuromaging and data analysis company Ixico Ltd.
While IXICO’s goal is early, pre-symptomatic diagnosis, the company is aware of the long-term challenge of delivering that scientific and...


